openPR Logo
Press release

Investigation announced for Investors in shares of Alpha and Omega Semiconductor Limited (NASDAQ: AOSL)

03-19-2020 06:49 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Alpha and Omega Semiconductor Limited (NASDAQ: AOSL) shares.

An investigation for investors in Alpha and Omega Semiconductor Limited (NASDAQ: AOSL) shares.

An investigation was announced over potential securities laws violations by Alpha and Omega Semiconductor Limited in connection with certain financial statements was announced.

Investors who purchased shares of Alpha and Omega Semiconductor Limited (NASDAQ: AOSL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on whether a series of statements by Alpha and Omega Semiconductor Limited regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Sunnyvale, CA based Alpha and Omega Semiconductor Limited designs, develops, and supplies power semiconductor products for computing, consumer electronics, communication, and industrial applications worldwide.
On February 5, 2020, post-market, Alpha and Omega Semiconductor Limited announced its financial results for the second fiscal quarter of 2020. Alpha and Omega Semiconductor Limited also disclosed that the U.S. Department of Justice "recently commenced an investigation into the Company's compliance with export control regulations relating to certain business transactions with Huawei and its affiliates ('Huawei')" and that "[i]n connection with this investigation, [the Department of Commerce] has requested the Company to suspend shipments of its products to Huawei . . . . Accordingly, we expect the financial performance in the March quarter will be negatively impacted by the Huawei shipment interruption and by additional professional fees incurred in connection with the investigation."
Shares of Alpha and Omega Semiconductor Limited (NASDAQ: AOSL) declined from $23.00 per share on January 8, 2017, to as low as $6.12per share on March 19, 2020.

Those who purchased shares of Alpha and Omega Semiconductor Limited (NASDAQ: AOSL) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Alpha and Omega Semiconductor Limited (NASDAQ: AOSL) here

News-ID: 1976322 • Views: 377

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Qurate Retail, Inc. (NASDAQ: …
Qurate Retail, Inc is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Qurate Retail, Inc. (NASDAQ: QRTEA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Qurate Retail, Inc. regarding its business, its prospects and its operations were materially false
Lawsuit filed for Investors in shares of Allakos Inc. (NASDAQ: ALLK)
An investor, who purchased shares of Allakos Inc. (NASDAQ: ALLK), filed a lawsuit over alleged Securities Laws violations by Allakos Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and for certain investors are short and strict deadlines running. Deadline: May 11, 2020. NASDAQ: ALLK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Investigation announced for Investors in NASDAQ:LNDC shares over potential Wrong …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors at Landec Corporation. Investors who purchased shares of Landec Corporation (NASDAQ: LNDC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Landec directors breached their fiduciary duties and caused damage to the company and its shareholders. Santa Clara, CA based Landec Corporation, together
Lawsuit filed for Investors in shares of PaySign, Inc. (NASDAQ: PAYS)
An investor, who purchased shares of PaySign, Inc. (NASDAQ: PAYS), filed a lawsuit over alleged Securities Laws violations by PaySign, Inc. Investors in shares of PaySign, Inc. (NASDAQ: PAYS) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 9, 2019, PaySign, Inc lowered its fiscal 2019 revenue guidance to a range of $35 million to $37 million, from prior guidance range of $38 million to $40

All 5 Releases


More Releases for Alpha

Geon Network Alpha App Reaches Major Milestone
December 11, 2018 – Gibraltar - Geon Network Limited (“GEON”, “Geon Network” or “Company”) today announced that the release of its Geon Network App (“GeonApp”) available at the Apple Store and Google Play has reached its first major milestone with over 10,000 user downloads. The initial alpha Geonapp was launched for Android OS on October 25, 2018 and for iOS on October 27, 2019. These are exciting times for the
Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2017, provides an overview of the Alpha- Antitrypsin Deficiency (Genetic Disorders) pipeline landscape. Alpha-antitrypsin deficiency is an inherited disease that occurs due to lack of alpha-1 antitrypsin (AAT),
Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C …
"The Report Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Alpha-2C adrenergic receptor or ADRA2C is an alpha-2 adrenergic receptor. It mediates the
Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017, provides an overview of the Alpha- Antitrypsin Deficiency (Genetic Disorders) pipeline landscape. Alpha-antitrypsin deficiency is an inherited disease that occurs due to lack of alpha-1 antitrypsin (AAT),
Global Alpha-Amylase Industry Report 2016
The report, ‘Global Alpha-Amylase Industry Report 2016’ provides detailed market and segment level data on the Global and Chinese consumption of Alpha-Amylase. The report provides historic, forecast and growth patterns by company, country and type/application from 2016 to 2021. This report delivers an extensive overview of Global Alpha-Amylase industry with a focus on China. It also acts as an essential tool to companies active across the value chain and to the
Alpha Trains introduces zedas®asset
Europe’s largest lessor of rail vehicles counts on PC-Soft’s solution for asset and leasing management for vehicle fleets Following an international request for proposals, Alpha Trains has now put its trust in zedas®asset. They were particularly impressed with the powerful, consistent functions for maintenance management for rail vehicle fleets, the creation of leasing contracts and the integrated mobile functionality. Upon conclusion of this project, zedas®asset will be available as an information platform